Abstract : Many reports have shown that human papillomavirus (HPV) plays an important role in the carcinogenesis of cervical adenocarcinoma. In the present study, 106 cases of uterine cervical adenocarcinoma, comprising 95 cases of adenocarcinoma and 11 cases of adenosquamous carcinoma, were examined for HPV-DNA using in situ hybridization (ISH). Using ISH, we were able to show the expression of HPV-DNA on a glass slide. Forty-eight of 106 cases (45.3%) of adenocarcinoma and adenosquamous carcinoma were positive for high-risk HPV-DNA according to ISH. Of 79 cases of invasive adenocarcinoma, 35 (44.3%) were positive for high-risk HPV-DNA, compared with eight of 16 cases (50%) of adenocarcinoma in situ. In the underlying non-neoplastic epithelium, positive foci were found in the squamous epithelium of 11 of 64 cases (17.2%), but no glandular or columnar epithelium was positive for HPV. HPV infection seems to play a role in the induction rather than the progression of cervical adenocarcinoma. High-risk HPV infection in the underlying squamous epithelium may be related to the carcinogenesis of adenocarcinoma, but there was no relationship found with the underlying glandular and columnar epithelium.
Introduction
Human papillomavirus (HPV) plays an important role in the carcinogenesis of cervical carcinoma, not only squamous cell carcinoma but also adenocarcinoma'.
Because of inactivation of the tumor suppressor proteins p53 and retinoblastoma protein (pRb) by the HPV oncoproteins E6 and E7, unrestricted cell proliferation results in tumor develop-ment6-9). In the present study, we used in situ hybridization (ISH) to visualize the localization of HPV-DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix, including the underlying dysplastic and non-neoplastic epithelium, on glass slides. In a previous study, we had investigated the correlation between the overexpression of tumor-related proteins (p16, Ki-67) and the presence of HPV-DNA (using ISH and polymerase chain reaction) and found that high p16 and Ki-67 expression was seen in most cases positive for HPV-DNA 10). In the present study, using ISH we examined the localization of HPV-DNA in adenocarcinoma and the underlying epithelium of the uterine cervix in 106 patients (68 cases from the previous study 100. Materials and Methods
Case selection
In all, 106 patients with cervical adenocarcinoma were enrolled from the archives of Tissue specimens for the detection of HPV-DNA by ISH One block containing the maximum amount of tumor tissue was selected from each of 89 hysterectomy, 11 Ionization and six biopsy specimens. All specimens were fixed in formaldehyde solution and embedded in paraffin after standard processing. For ISH analysis, the BENCHMARK fully automated slide-preparation system was used (Ventana Medical Systems, Tucson, AZ, USA) ; it is a catalyzed signal-amplification system that uses biotinylated probes for the immunochemical detection of 15 high-risk HPV types (HPV-16, -18, -31, -33 , -35, -39, -45, -51, -52, -56, -58, -59, and -68) and five low-risk HPV types (HPV-6, -11, -42 , -43 and -44). Automated processing includes baking, deparaffinization, cell conditioning, staining, and counterstaining. HPV-DNA is indicated by the pale blue (low copy number) to blue-black (high copy number) staining of the nucleus of infected cells'.
In the present study, tissues were classified as positive for HPV-DNA when there was more than one epithelial cell per specimen showing pale blue to blue-black staining, either focal or diffuse.
Results
Clinicopathological features and histological subtypes of invasive adenocarcinoma are summarized in Tables 1 and 2 . Most cases were classified as stage I (38 cases), followed by stage II (17 cases), at the time of diagnosis. Regarding surgery and additional therapy, most cases underwent a hysterectomy, and about a half of the cases had no additional therapy or post-operative chemotherapy. As for outcome, 13 cases of 82 operative cases showed after operative recurrence. As shown in Table 2 , the major subtype of adenocarcinoma was endocervical (52 cases ; 49.1%), followed by endometrioid (12 cases 11.3%), adenosquamous carcinoma (11 cases ; 10.4%), and intestinal (seven cases ; 6.6%). investigated. A positive reaction, characterized by single or multiple dot-like signals, was seen in the nuclei of cancer cells but not in normal columnar epithelium, including the adjoining epithelium (Fig. la, b) . Of the 79 cases of invasive adenocarcinoma, 35 (44.3%) were positive for high-risk HPV-DNA, compared with eight of 16 cases (50%) of AIS. Thus, the positive rate for high-risk HPV-DNA was almost the same in these two groups.
In the underlying non-neoplastic epithelium, in 11 of 64 cases the squamous epithelium was found to be positive for high-risk HPV-DNA (Fig. 2, 3) ; all samples of glandular and columnar epithelium investigated were negative. Low-risk HPV types were not detected in any of the cases investigated, including in the underlying non-neoplastic epithelium. According to previous studies using ISH, high-risk HPV types are detected in 17.9 %-83.3% of cases of cervical adenocarcinoma 12-'6). In the present study, 48 of 106 cases (45.3%) of adenocarcinoma and adenosquamous carcinoma were positive for high-risk HPV-DNA according to ISH analysis. This agrees with the results of our previous study, in which 27 of 68 cases (39.7%) were positive for high-risk HPV-DNA 10~. The incidence of HPV-DNA positivity in cervical adenocarcinoma is rather low compared with results obtained in recent studies using polymerase chain reaction (PCR) 2.3,17-t9) and other HPV detection methods. There are three possible explanations for the low incidence of HPV-DNA in the present study. First, small and I or the poor quality of specimens for ISH resulting from prolonged or inadequate fixation may have reduced the positive signal on ISH. Second, the poor sensitivity of the technique used in the present study may have contributed to the low incidence of HPV-DNA detection compared with PCR methods. Third, there was a small amount of HPV-DNA (low copy number) in the nuclei of most adenocarcinoma cells compared with that in squamous cell carcinoma, as indicated by the pale blue staining of the nuclei of infected cells.
The most important aspect of the present study is that by using ISH we were able to visualize the localization of HPV-DNA on a glass slide, not only in the carcinoma, but also in the underlying non-neoplastic epithelium. In the underlying non-neoplastic epithelium, in 11 of 64 cases (17.2%) the squamous epithelium was positive for HPV-DNA, whereas all samples of glandular or columnar epithelium were negative.
In the present study, 35 of 79 cases (44.3%) of invasive adenocarcinoma and eight of 16 cases (50%) of AIS were positive for high-risk HPV-DNA. A few HPV-DNA-positive cells were seen in the non-neoplastic squamous epithelium, but no positive reaction was observed in the non-neoplastic columnar or glandular epithelium. These results suggest that HPV infection plays a role in the induction rather than the progression of cervical adenocarcinoma, and that HPV infection in the underlying squamous epithelium may be related to the carcinogenesis of cervical adenocarcinoma. There does not appear to be any relationship between cervical adenocarcinoma and HPV infection in the underlying glandular and columnar epithelium.
Using ISH, we were able to visualize the expression of HPV-DNA on a glass slide. ISH is a useful method to study the relationship between HPV infection and the carcinogenesis of cervical adenocarcinoma.
